What paleontologists learned from fossils of a 3-eyed predator that lived 500 million years ago
The fossils of Mosura fentoni -- a species of arthropod that lived in the Cambrian Period -- were discovered in Burgess Shale in the Canadian Rockies, a region known for its exceptional preservation of fossils, according to a paper published Wednesday in Royal Society Open Science.
The species belongs to a group of arthropods nicknamed "sea moths" that use a flap-like apparatus similar to wings to help them swim, the authors said in a statement. The mechanism gives the species a "vague appearance" to a moth and are distantly related to modern moths, spiders, crabs and millipedes.
MORE: Underwater camera captures elusive tentacled creature 3 miles below ocean surface
The 506 million-year-old fossil is an imprint of a creature that had three eyes, a jaw lined with teeth, sharp claws and abdominal segments lined with gills. However, the specimen is not a fish, the researchers said. It belongs to the radiodont group, an ancient line of sea predators that are now instinct.
"Radiodonts were the first group of arthropods to branch out in the evolutionary tree, so they provide key insight into ancestral traits for the entire group," said Jean-Bernard Caron, curator of invertebrate paleontology at the Royal Ontario Museum, in a statement.
Several of the fossils are so clear that they show details of the specimen's internal anatomy, including parts of the nervous and circulatory systems and digestive tract, Caron said, describing the details as "astounding."
"Very few fossil sites in the world offer this level of insight into soft internal anatomy," Caron said. "We can see traces representing bundles of nerves in the eyes that would have been involved in image processing, just like in living arthropods."
MORE: What scientists learned from a well-preserved fossil of this iconic Jurassic-era species
The species had an open circulatory system that pumped blood into large internal body cavities called lacunae, which were preserved as reflective patches in the fossils.
The new species emphasizes that these early arthropods were already surprisingly diverse and were adapting in a comparable way to their distant modern relatives
Even more surprising than Mosura fentoni's three eyes is a tail-like body made of segments lined with gills on its abdomen -- something never before seen on a radiodont. The researchers compared its rear section to modern arthropods such as insects and horseshoe crabs.
"This is a neat example of evolutionary convergence with modern groups, like horseshoe crabs, woodlice, and insects, which share a batch of segments bearing respiratory organs at the rear of the body,' said Joe Moysiuk, curator of paleontology and geology at the Manitoba Museum and lead author of the study, in a statement.
MORE: Scientists discover 'legless, headless wonder' that predated the dinosaurs
The "intriguing" adaption may be the result of habitat preference of behavioral characteristics of the species that required more efficient respiration, the researchers said.
The Burgess Shale fossil sites, designated a UNESCO World Heritage Site in 1980, are located within the Yoho and Kootenay National Parks.
Dozens of Mosura fossils have been collected in Burgess Shale in recent decades, according to the paper.
What paleontologists learned from fossils of a 3-eyed predator that lived 500 million years ago originally appeared on abcnews.go.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 hours ago
- Yahoo
AbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial Results
We recently published . AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best healthcare stocks. AbCellera Biologics Inc. (NASDAQ:ABCL) is a biotech company specializing in discovering and developing therapeutic antibodies across various disease areas, including cancer, metabolic, endocrine, and autoimmune disorders. Their integrated platform combines technology, data science, and collaboration to identify promising antibody candidates. In recent developments, AbCellera Biologics Inc. (NASDAQ:ABCL) began dosing participants in a Phase 1 clinical trial for ABCL635, targeting vasomotor symptoms related to menopause, marking a key clinical milestone. The company reported strong Q2 2025 revenue growth, beating expectations and advancing both internal and partnered antibody programs despite ongoing net losses. Some analysts note that its innovative pipeline and expanding clinical presence could place it among the best healthcare stocks to watch in the biotech space. Photo by Myriam Zilles on Unsplash This Phase 1 trial signals the corporation's shift from primarily a discovery platform to a clinical-stage biotech with proprietary assets. Progress with ABCL635 addresses a significant unmet medical need and validates its platform's potential to develop first-in-class therapeutics. While we acknowledge the potential of ABCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Fox News
3 days ago
- Fox News
Divers reveal images of 321-year-old shipwreck in remarkable condition off coast
A preserved shipwreck from 1703 was recently documented in stunning detail for the first time – with experts cautioning that it may not stay this way for very long. Researchers dove off the coast of Kent, England, to view the wreck of "The Northumberland" last summer. The Stuart-era ship was built in 1679 and sank during the Great Storm of 1703. (See the video at the top of this article.) The site was designated a Protected Wreck Site in 1981 — but it hasn't been seen so clearly until now. Officials revealed the results of the dive on July 31, sharing pictures of a shipwreck covered by marine sediment. The sands have aided the survival of the wreck, which is roughly 50 to 65 feet underwater. The dive was conducted by Historic England, British coastal contractor MSDS Marine and Dan Pascoe, the licensee of the wreck. Historic England told Fox News Digital that divers found an extensive hull structure, exposed deck planks and the wooden frame of the ship – which is "much more than previously thought." Among the finds were multiple wooden chests – some still containing musketballs – as well as one sealed chest with unknown contents. Researchers also came across seven iron cannons, along with copper cauldrons and rope. Experts cited shifting sands as the main threat to the wreck. Hefin Meara, a maritime archaeologist at Historic England, told Fox News Digital the sand on the coast of England is "highly dynamic." Only the most robust materials, such as anchors and iron cannons, tend to survive. "The Goodwin Sands provide an excellent environment for the preservation of organic material, such as ship timbers, rope and other objects," he said. "Once the sand cover migrates away from the wreck site, biological and physical processes can cause the wreck to deteriorate very quickly," he also said. "'The Northumberland' has so much potential to tell us more about the English Navy and ships of the period." He noted that archaeologists will continue focusing on surveying the site instead of removing the artifacts, which could jeopardize the integrity of the site. Pascoe noted that "The Northumberland" "has the potential to be one of the best-preserved wooden warships in the U.K." MSDS's Alison James emphasized the wealth of information that the wreck could provide about the Stuart era. "'The Northumberland' has so much potential to tell us more about the English Navy and ships of the period," she said. Many historic shipwrecks have been found and documented across the United Kingdom in recent years. In Feb. 2024, a teenager found an American Revolution warship on a Scottish beach. More recently, a former military pilot identified a 19th-century shipwreck in the English Channel.
Scientific American
4 days ago
- Scientific American
New Brain Device Is First to Read Out Inner Speech
After a brain stem stroke left him almost entirely paralyzed in the 1990s, French journalist Jean-Dominique Bauby wrote a book about his experiences—letter by letter, blinking his left eye in response to a helper who repeatedly recited the alphabet. Today people with similar conditions often have far more communication options. Some devices, for example, track eye movements or other small muscle twitches to let users select words from a screen. And on the cutting edge of this field, neuroscientists have more recently developed brain implants that can turn neural signals directly into whole words. These brain-computer interfaces (BCIs) largely require users to physically attempt to speak, however—and that can be a slow and tiring process. But now a new development in neural prosthetics changes that, allowing users to communicate by simply thinking what they want to say. The new system relies on much of the same technology as the more common 'attempted speech' devices. Both use sensors implanted in a part of the brain called the motor cortex, which sends motion commands to the vocal tract. The brain activation detected by these sensors is then fed into a machine-learning model to interpret which brain signals correspond to which sounds for an individual user. It then uses those data to predict which word the user is attempting to say. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. But the motor cortex doesn't only light up when we attempt to speak; it's also involved, to a lesser extent, in imagined speech. The researchers took advantage of this to develop their 'inner speech' decoding device and published the results on Thursday in Cell. The team studied three people with amyotrophic lateral sclerosis (ALS) and one with a brain stem stroke, all of whom had previously had the sensors implanted. Using this new 'inner speech' system, the participants needed only to think a sentence they wanted to say and it would appear on a screen in real time. While previous inner speech decoders were limited to only a handful of words, the new device allowed participants to draw from a dictionary of 125,000 words. 'As researchers, our goal is to find a system that is comfortable [for the user] and ideally reaches a naturalistic ability,' says lead author Erin Kunz, a postdoctoral researcher who is developing neural prostheses at Stanford University. Previous research found that 'physically attempting to speak was tiring and that there were inherent speed limitations with it, too,' she says. Attempted speech devices such as the one used in the study require users to inhale as if they are actually saying the words. But because of impaired breathing, many users need multiple breaths to complete a single word with that method. Attempting to speak can also produce distracting noises and facial expressions that users find undesirable. With the new technology, the study's participants could communicate at a comfortable conversational rate of about 120 to 150 words per minute, with no more effort than it took to think of what they wanted to say. Like most BCIs that translate brain activation into speech, the new technology only works if people are able to convert the general idea of what they want to say into a plan for how to say it. Alexander Huth, who researches BCIs at the University of California, Berkeley, and wasn't involved in the new study, explains that in typical speech, 'you start with an idea of what you want to say. That idea gets translated into a plan for how to move your [vocal] articulators. That plan gets sent to the actual muscles, and then they carry it out.' But in many cases, people with impaired speech aren't able to complete that first step. 'This technology only works in cases where the 'idea to plan' part is functional but the 'plan to movement' part is broken'—a collection of conditions called dysarthria—Huth says. According to Kunz, the four research participants are eager about the new technology. 'Largely, [there was] a lot of excitement about potentially being able to communicate fast again,' she says—adding that one participant was particularly thrilled by his newfound potential to interrupt a conversation—something he couldn't do with the slower pace of an attempted speech device. To ensure private thoughts remained private, the researchers implemented a code phrase: 'chitty chitty bang bang.' When internally spoken by participants, this would prompt the BCI to start or stop transcribing. Brain-reading implants inevitably raise concerns about mental privacy. For now, Huth isn't concerned about the technology being misused or developed recklessly, speaking to the integrity of the research groups involved in neural prosthetics research. 'I think they're doing great work; they're led by doctors; they're very patient-focused. A lot of what they do is really trying to solve problems for the patients,' he says, 'even when those problems aren't necessarily things that we might think of,' such as being able to interrupt a conversation or 'making a voice that sounds more like them.' For Kunz, this research is particularly close to home. 'My father actually had ALS and lost the ability to speak,' she says, adding that this is why she got into her field of research. 'I kind of became his own personal speech translator toward the end of his life since I was kind of the only one that could understand him. That's why I personally know the importance and the impact this sort of research can have.' The contribution and willingness of the research participants are crucial in studies like this, Kunz notes. 'The participants that we have are truly incredible individuals who volunteered to be in the study not necessarily to get a benefit to themselves but to help develop this technology for people with paralysis down the line. And I think that they deserve all the credit in the world for that.'
